16
Views
1
CrossRef citations to date
0
Altmetric
Review

Reproductive concerns of children and adolescents with cancer: challenges and potential solutions

, , , , &
Pages 63-78 | Published online: 11 Jun 2013

References

  • Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–241.
  • American Cancer Society. Cancer treatment and survivorship facts and figures [web page on the Internet]. Atlanta, GA: American Cancer Society; nd. Available from: http://www.cancer.org/research/cancerfactsfigures/cancertreatmentsurvivorshipfactsfigures/index. Accessed April 6, 2013.
  • Cancer (AIHW) [homepage on the Internet]. Australian Institute of Health and Welfare, Australian Cancer Database, 2013. Available from: http://www.aihw.gov.au/cancer-data/.
  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Globocan 2008: cancer incidence and mortality worldwide: IARC Cancerbase No 10 [data on the Internet]. Lyon: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr. Accessed April 11, 2011.
  • Thursfield V Farrugia H, Karahalios E, Giles G. Cancer Survival Victoria 2012: Estimates of survival in 2006–2010 (and comparisons with earlier periods). Melbourne, Australia; Cancer Council Victoria; 2012. Available from: http://www.cancervic.org.au/downloads/cec/ cancer-survival-victoria-2012.pdf. Accessed April 11, 2011.
  • Pui CH, Gajjar AJ, Kane JR, Qaddoumi IA, Pappo AS. Medscape. Challenging issues in pediatric oncology. Nat Rev Clin Oncol. 2011;8(9):540–549.
  • Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23(3):699–708.
  • Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;55(1):e8772.
  • Anderson RA, Themmen AP, Al-Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod. 2006;21(10):2583–2592.
  • Levine J, Canada A, Stern CJ. Fertility preservation in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4831–4841.
  • Anderson RA, Wallace WH. Fertility preservation in girls and young women. Clin Endocrinol (Oxf). 2011;75(4):409–419.
  • Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010;53(4):727–739.
  • Meirow D, Dor J, Kaufman B, et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod. 2007;22(6):1626–1633.
  • Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin’s disease. Cancer. 1983;52(6):988–993.
  • Youlden D, Baade P, Ward L, et al. Childhood Cancer Incidence in Australia, 1983–2006. Brisbane: Viertel Centre for Research in Cancer Control, Cancer Council Queensland, and Australian Paediatric Cancer Registry; 2009. Available from: http://www.cancerqld.org.au/icms_docs/60370_Childhood_cancer_incidence_in_Australia_1983_-_2006. pdf. Accessed April 11, 2013.
  • De Bruin ML, Huisbrink J, Hauptmann M, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood. 2008;111(1):101–108.
  • Thomson AB, Critchley HO, Kelnar CJ, Wallace WH. Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. Best Pract Res Clin Endocrinol Metab. 2002;16(2):311–334.
  • Wallace HB, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18(1):117–121.
  • Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738–744.
  • Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol. 1999;33(1):2–8.
  • Lushbaugh CC, Casarett GW The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer. 1976;37(Suppl 2):1111–1125.
  • Sanders JE, Hawley J, Levy W, et al. Pregnancies following highdose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87(7):3045–3052.
  • Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol). 1989;1(2):75–79.
  • Bath LE, Critchley HO, Chambers SE, Anderson RA, Kelnar CJ, Wallace WH. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol 1999;106(12):1265–1272.
  • Chiarelli AM, Marrett LD, Darlington GA. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology. 2000;11(2):161–166.
  • Critchley HO, Wallace WH, Shalet SM, Mamtora H, Higginson J, Anderson DC. Abdominal irradiation in childhood; the potential for pregnancy. Br J Obstet Gynaecol. 1992;99(5):392–394.
  • Holm K, Nysom K, Brocks V, Hertz H, Jacobsen N, Müller J. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplant. 1999;23(3):259–263.
  • Green DM, Peabody EM, Nan B, Peterson S, Kalapurakal JA, Breslow NE. Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2002;20(10):2506–2513.
  • Green DM, Lange JM, Peabody EM, et al. Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study. J Clin Oncol. 2010;28(17):2824–2830.
  • Green DM, Sklar CA, Boice JD Jr, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study, J Clin Oncol. 2009;27(14):2374–2381.
  • Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update. 2005;11(1):69–89.
  • van Disseldorp J, Lambalk CB, Kwee J, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod. 2010;25(1):221–227.
  • Lie Fong S, Laven JS, Hakvoort-Cammel FG, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum Reprod. 2009;24(4):982–990.
  • Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online. 2010;20(2):280–285.
  • Stern C. . Future fertility for young women with cancer: protection, preservation, or both. In: Kovacs G, editor. How to Improve Your ART Success Rates: An Evidence-Based Review of Adjuncts to IVF. Cambridge, UK: Cambridge University Press; 2011:226–234.
  • Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18(6):769–776.
  • Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96(2):277–285.
  • Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update. 2007;13(6):591–605.
  • Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010;94(2):389–400.
  • Junk SM, Yeap D. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome. Fertil Steril. 2012;98(4):888–892.
  • Silber SJ, Woodruff TK, Shea LD. To transplant or not to transplant – that is the question. Cancer Treat Res. 2010;156:41–54.
  • Jansen FW, Kolkman W, Bakkum EA, de Kroon CD, Trimbos-Kemper TC, Trimbos JB. Complications of laparoscopy: an inquiry about closed- versus open-entry technique. Am J Obstet Gynecol. 2004;190(3):417–422.
  • Schmidt KL, Andersen CY, Loft A, Byskov AG, Ernst E, Andersen AN. Follow-up of ovarian function post-chemotherapy following ovarian cryo- preservation and transplantation. Hum Reprod. 2005;20(12):3539–3546.
  • Gook DA, Edgar DH, Borg J, et al. Oocyte maturation, follicle rupture and luteinisation in human cryopreserved ovarian tissue following xenografting. Hum Reprod. 2003;18(9):1772–1781.
  • Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Orthotopic and heterotopic ovarian tissue transplantation. Hum Reprod Update. 2009;15(6):649–665.
  • Domans MM, Donnez J, Camboni A, et al. IVF outcome in patients with orthotopically transplanted ovarian tissue. Hum Reprod. 2009;24(11):2778–2787.
  • Demeestere I, Basso O, Moffa F, Peccatori F, Poirot C, Shalom-Paz E. Fertility preservation in female cancer patients. Obstet Gynecol Int. Epub October 20, 2012.
  • Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364(9443):1405–1410.
  • Dittrich R, Lotz L, Keck G, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012;97(2):387–390.
  • Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;43(6):437–450.
  • Revel A, Laufer N, Ben Meir A, Lebovich M, Mitrani E. Micro-organ ovarian transplantation enables pregnancy: a case report. Hum Reprod. 2011;26(5):1097–1103.
  • Silber SJ. Ovary cryopreservation and transplantation for fertility preservation. Mol Hum Reprod. 2012;18(2):59–67.
  • Martinez F, Devesa M, Coroleu B, et al. Cancer and fertility preservation: Barcelona consensus meeting. Gynecol Endocrinol. 2013;29(4):285–291.
  • Andersen CY, Silber SJ, Berghold SH, Jorgensen JS, Ernst E. Long-term duration of function of ovarian tissue transplants: case reports. Reprod Biomed Online. 2012;25(2):128–132.
  • Silber S, Kagawa N, Kuwayama M, Gosden R. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010;94(6):2191–2196.
  • Meirow D, Hardan I, Dor J, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23(5):1007–1013.
  • Rosendahl M, Andersen MT, Ralfki^r E, Kjeldsen L, Andersen MK, Andersen CY. Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. Fertil Steril. 2010;94(6):2186–2190.
  • Greve T, Clasen-Linde E, Andersen MT, et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120(22):4311–4316.
  • Seshadri T, Gook D, Lade S, et al. Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. Br J Cancer. 2006;94(7):1007–1010.
  • Salle B, Demirci B, Franck M, Rudigoz RC, Guerin JF, Lornage J. Normal pregnancies and live births after autograft of frozen-thawed hemi-ovaries into ewes. Fertil Steril. 2002;77(2):403–408.
  • Bedaiwy MA, Shahin AY, Falcone T. Reproductive organ transplantation: advances and controversies. Fertile Steril. 2008;90(6):2031–2055.
  • Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. 2008;89(3):567–572.
  • Xu M, Barrett SL, West-Farrell E, et al. In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum Reprod. 2009;24(10):2531–2540.
  • Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update. 2008;14(6):543–552.
  • Meirow D, Assad G, Dor J, Rabinovici J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod. 2004;19(6):1294–1299.
  • Beck-Fruchter R, Weiss A, Shalev E. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update. 2008;14(6):553–561.
  • Clowse ME, Behera MA, Anders CK, et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt). 2009;18(3):311–319.
  • Bedaiwy MA, Abou-Setta AM, Desai N, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):906–914.
  • Gerber B, von Minckwitz G, Stehle H, et al; German Breast Group Investigators. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011;29(17):2334–2341.
  • Fishel Bartal M, Carmely A, Kalechman Y, Sredni B, Meirow D. The protective effect of the immunomodulator AS101 against chemotherapy-induced female reproductive damage. IMAJ 2009;11:575–576.
  • Kerr JB, Hutt KJ, Michalak EM, et al. DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol Cell. 2012;48(3):343–352.
  • Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril. 2000;74(4):743–748.
  • Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–2931.
  • Kenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001;91(3):613–621.
  • van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, Hählen K, Dohle GR, van den Heuvel-Eibrink MM. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer. 2009;52(1):108–112.
  • van Alphen MM, van de Kant HJ, de Rooij DG. Depletion of the spermatogonia from the seminiferous epithelium of the rhesus monkey after X irradiation. Radiat Res. 1988;113(3):473^486.
  • de Rooij DG, van de Kant HJ, Dol R, et al. Long-term effects of irradiation before adulthood on reproductive function in the male rhesus monkey. Biol Reprod. 2002;66(2):486–494.
  • Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–17.
  • Anserini P, Chiodi S, Spinelli S, et al. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence- based counselling. Bone Marrow Transplant. 2002;30(7):447–451.
  • Sklar CA, Robison LL, Nesbit ME, et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol. 1990;8(12):1981–1987.
  • Shalet SM, Tsatsoulis A, Whitehead E, Read E. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol. 1989;120(1):161–165.
  • Brauner R, Czernichow P, Cramer P, Schaison G, Rappaport R. Leydig- cell function in children after direct testicular irradiation for acute lymphoblastic leukemia. N Engl J Med. 1983;309(1):25–28.
  • Heikens J, Behrendt H, Adriaanse R, Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin’s disease. Cancer. 1996;78(9):2020–2024.
  • Bramswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin’s disease during childhood or adolescence. Cancer. 1990;65(6):1298–1302.
  • Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6(4):209–218.
  • Aubier F, Flamant F, Brauner R, Caillaud JM, Chaussain JM, Lemerle J. Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol. 1989;7(3):304–309.
  • Nurmio M, Keros V, Lahteenmaki P, Salmi T, Kallajoki M, Jahnukainen K. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility. J Clin Endocrinol Metab. 2009;94(6):2119–2122.
  • Ridola V Fawaz O, Aubier F, et al. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. Eur J Cancer. 2009;45(5):814–818.
  • Meistrich ML, Wilson G, Brown BW, da Cunha MF, Lipshultz LI. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer. 1992;70(11):2703–2712.
  • Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA. 1988;259(14):2123–2125.
  • Gurgan T, Salman C, Demirol A. Pregnancy and assisted reproduction techniques in men and women after cancer treatment. Placenta. 2008;29 Suppl B:152–159.
  • Wyns C, Curaba M, Vanabelle B, Van Langendonckt A, Donnez J. Options for fertility preservation in prepubertal boys. Hum Reprod Update. 2010;16(3):312–328.
  • Kreuser ED, Xiros N, Hetzel WD, Heimpel H. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin’s disease. J Cancer Res Clin Oncol. 1987;113(3):260–266.
  • Bokemeyer C, Schmoll HJ, van Rhee J, Kuczyk M, Schuppert F, Poliwoda H. Long-term gonadal toxicity after therapy for Hodgkin’s and non-Hodgkin’s lymphoma. Ann Hematol. 1994;68(3):105–110.
  • Waxman J. Chemotherapy and the adult gonad: a review. J R Soc Med. 1983;76(2):144–148.
  • Waxman J, Terry Y, Rees LH, Lister TA. Gonadal function in men treated for acute leukaemia. Br Med J (Clin Res Ed). 1983;287(6399):1093–1094.
  • Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15(6):608–613.
  • Ash P. The influence of radiation on fertility in man. Br J Radiol. 1980;53(628):271–278.
  • Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59(3):665–678.
  • Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997;130(2):210–216.
  • Bahadur G, Ling KL, Hart R, et al. Semen quality and cryopreservation in adolescent cancer patients. Hum Reprod. 2002;17(12):3157–3161.
  • Kamischke A, Jürgens H, Hertle L, Berdel WE, Nieschlag E. Cryopreservation of sperm from adolescents and adults with malignancies. J Androl. 2004;25(4):586–592.
  • Barak S, . Baker HW Clinical management of male infertility. In: McLachlan R, editor. Endocrinology of Male Reproduction. South Dartmouth, MA: Endotext.org; 2012. Available at: http://www.endotext. org/male/male7/maleframe7.htm. Accessed April 11, 2013.
  • Agarwal A, Said TM. Role of sperm chromatin abnormalities and DNA damage in male infertility. Hum Reprod Update. 2003;9(4):331–345.
  • Feldschuh J, Brassel J, Durso N, Levine A. Successful sperm storage for 28 years. Fertil Steril. 2005;84(4):1017.
  • Sharma V Sperm storage for cancer patients in the UK: a review of current practice. Hum Reprod. 2011;26(11):2935–2943.
  • Brook PF, Radford JA, Shalet SM, Joyce AD, Gosden RG. Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation. Fertil Steril. 2001;75(2):269–274.
  • Hovatta O. Cryopreservation of testicular tissue in young cancer patients. Hum Reprod Update. 2001;7(4):378–383.
  • Keros V Rosenlund B, Hultenby K, Aghajanova L, Levkov L, Hovatta O. Optimizing cryopreservation of human testicular tissue: comparison of protocols with glycerol, propanediol and dimethylsulphoxide as cryoprotectants. Hum Reprod. 2005;20(6):1676–1687.
  • Keros V Hultenby K, Borgström B, Fridström M, Jahnukainen K, Hovatta O. Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod. 2007;22(5):1384–1395.
  • Stukenborg JB, Schlatt S, Simoni M, et al. New horizons for in vitro spermatogenesis? An update on novel three-dimensional culture systems as tools for meiotic and post-meiotic differentiation of testicular germ cells. Mol Hum Reprod. 2009;15(9):521–529.
  • Sato T, Katagiri K, Gohbara A, et al. In vitro production of functional sperm in cultured neonatal mouse testes. Nature. 2011;471(7339):504–507.
  • Geens M, Van de Velde H, De Block G, Goossens E, Van Steirteghem A, Tournaye H. The efficiency of magnetic-activated cell sorting and fluorescence-activated cell sorting in the decontamination of testicular cell suspensions in cancer patients. Hum Reprod. 2007;22(3):733–742.
  • Fujita K, Tsujimura A, Miyagawa Y, et al. Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy. Cancer Res. 2006;66(23):11166–11171.
  • Luetjens CM, Stukenborg JB, Nieschlag E, Simoni M, Wistuba J. Complete spermatogenesis in orthotopic but not in ectopic transplants of autologously grafted marmoset testicular tissue. Endocrinology. 2008;149(4):1736–1747.
  • Geens M, De Block G, Goossens E, Frederickx V, Van Steirteghem A, Tournaye H. Spermatogonial survival after grafting human testicular tissue to immunodeficient mice. Hum Reprod. 2006;21(2):390–396.
  • Schlatt S, Honaramooz A, Ehmcke J, et al. Limited survival of adult human testicular tissue as ectopic xenograft. Hum Reprod. 2006;21(2):384–389.
  • Clinical Oncological Society of Australia. Fertility Preservation for AYAs Diagnosed with Cancer: Guidance for Health Professionals. Sydney: Clinical Oncological Society of Australia; nd [updated October 17, 2012]. Available from: http://wiki.cancer.org.au/australia/ COSA:AYA_cancer_fertility_preservation. Accessed April 11, 2013.
  • National Comprehensive Cancer Network, Clinical Practice Guidelines for Adolescents and Young Adults (AYA) with cancer. 2012, National Comprehensive Cancer Network: Washington.
  • Fallat ME, Hutter J; American Academy of Pediatrics Committee on Bioethics; American Academy of Pediatrics Section on Hematology/ Oncology; American Academy of Pediatrics Section on Surgery. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics. 2008;121(5):e1461–e1469.
  • Anderson RA, Weddell A, Spoudeas HA, et al. Do doctors discuss fertility issues before they treat young patients with cancer? Hum Reprod. 2008;23(10):2246–2251.
  • Klosky JL, Randolph ME, Navid F, et al. Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol. 2009;26(4):252–260.
  • Forman EJ, Anders CK, Behera MA. Pilot survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. J Reprod Med. 2009;5(4):203–207.
  • Mitchell W, Clarke S, Sloper P. Care and support needs of children and young people with cancer and their parents. Psychooncology. 2006;15(9):805–816.
  • Zebrack BJ, Zeltzer LK, Whitton J, et al. Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin’s disease, and non-Hodgkin’s lymphoma: a report from the Childhood Cancer Survivor Study. Pediatrics. 2002;110(1 Pt 1):42–52.
  • Schover LR. Patient attitudes toward fertility preservation. Pediatric Blood Cancer. 2009;53(2):281–284.
  • Borgmann-Staudt A, Rendtorff R, Reinmuth S, et al. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant. 2012;47(2):271–276.
  • Chapple A, Salinas M, Ziebland S, et al. Fertility issues: the perceptions and experiences of young men recently diagnosed and treated for cancer. J Adolesc Health. 2007;40(1):69–75.
  • Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y. Sperm cryo- preservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer. 2005;104(3):521–524.
  • Crawshaw M, Sloper P. ‘Swimming against the tide’ – the influence of fertility matters on the transition to adulthood or survivorship following adolescent cancer. Eur J Cancer Care (Engl). 2010;19(5):610–620.
  • Wilkes S, Coulson S, Crosland A, Rubin G, Stewart J. Experience of fertility preservation among younger people diagnosed with cancer. Human Fert (Camb). 2010;13(3):151–158.
  • Quinn GP, Vadaparampil ST, Jacobsen PB, et al. Frozen hope: fertility preservation for women with cancer. J Midwifery Womens Health. 2010;55(2):175–180.
  • Pivetta E, Maule MM, Pisani P, et al; Italian Association of Pediatric Hematology and Oncology (AIEOP) Group. Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry. Haematologica. 2011;96(5):744–751.
  • Madanat LM, Malila N, Dyba T, et al. Probability of parenthood after early onset cancer: a population-based study. Int J Cancer. 2008;123(12):2891–2898.
  • Zebrack BJ, Casillas J, Nohr L, Adams H, Zeltzer LK. Fertility issues for young adult survivors of childhood cancer. Psychooncology. 2004;13(10):689–699.
  • Oosterhuis BE, Goodwin T, Kiernan M, Hudson MM, Dahl GV. Concerns about infertility risks among pediatric oncology patients and their parents. Pediatr Blood Cancer. 2008;50(1):85–89.
  • Quinn GP, Murphy D, Knapp C, et al. Who decides? Decision making and fertility preservation in teens with cancer: a review of the literature. J Adolesc Health. 2011;49(4):337–346.
  • Burns KC, Boudreau C, Panepinto JA. Attitudes regarding fertility preservation in female adolescent cancer patients. J Pediatr Hematol Oncol. 2006;28(6):350–354.
  • Knapp C, Quinn G. Assessing the reproductive concerns of children and adolescents with cancer: challenges and potential solutions. J Adolesc Young Adult Oncol. 2011;1(1):31–35.
  • Wallace WH, Critchely HO, Anderson RA. Optimizing reproductive outcome in children and young people with cancer. J Clin Oncol. 2012;30(1):3–5.
  • Wuchty S, Jones BF, Uzzi B. The increasing dominance of teams in production of knowledge. Science. 2007;36(36):1036–1039.
  • Gardino SL, Jeruss JS, Woodruff TK. Using decision trees to enhance interdisciplinary team work: the case of oncofertility. J Assist Reprod Genet. 2010;27(5):227–231.
  • Scott-Trainer J. The role of a patient navigator in fertility preservation. In: Woodruff TK, Zoloth L, Campo-Engelstein L, Rodriguez S, editors. Oncofertility. Berlin and Heidelberg: Springer; 2010:469–470.
  • Jona K, Gerber A. . MyOncofertility.org: a web-based patient education resource supporting decision making under severe emotional and cognitive overload. In: Woodruff TK, Zoloth L, Campo-Engelstein L, Rodriguez S, editors. Oncofertility. Berlin and Heidelberg: Springer; 2010:345–361.
  • Aleem IS, Jalal H, Aleem IS, Sheikh AA, Bhandari M. Clinical decision analysis: incorporating the evidence with patient preferences. Patient Prefer Adherence. 2009;3(1):21–24.
  • Hunink MG, Glasziou P, Siegel J, et al. Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge, UK: Cambridge University Press; 2001.
  • Frosch DL, Kaplan RM, Felitti VJ. A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med. 2003;18(10):781–787.
  • Grundy R, Gosden RG, Hewitt M, et al. Fertility preservation for children treated for cancer (1): scientific advances and research dilemmas. Arch Dis Child. 2001;84(4):355–359.
  • Grundy R, Larcher V, Gosden RG, et al. Fertility preservation for children treated for cancer (2): ethics of consent for gamete storage and experimentation. Arch Dis Child. 2001;84(4):360–362.
  • Albertini DF. Preserving integrity, along with fertility. J Assist Reprod Genet. 2012;29(6):463–464.
  • Tobias JS. BMJ’s present policy (sometimes approving research in which patients have not given fully informed consent) is wholly correct. BMJ. 1997;314(7087):1111–1114.
  • Nuffield Council on Bioethics. Human Tissues: Ethical and Legal Issues. London: Nuffield Council on Bioethics; 1995. Available from: http://www.nuffieldbioethics.org/sites/default/files/Human%20tissue. pdf. Accessed April 11, 2013.
  • Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol. 2011;8(1):56–60.
  • Waxman JH, Ahmed R, Smith D, et al. Failure to preserve fertility in patients with Hodgkin’s disease. Cancer Chemother Pharmacol. 1987;19:159–162.
  • Pereyra Pacheco B, Mendez Ribas JM, Milone G, et al. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol. 2001;81:391–397.
  • Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr. 2005;34:40–43.
  • Dann EJ, Epelbaum R, Avivi I, et al. Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. Hum Reprod. 2005;20:2247–2249.
  • Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum. 2005;52:2761–2767.
  • Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology. 2007;12:141–147.
  • Badawy A, Elnashar A, El-Ashry M, and Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril. 2009;91:694–697.
  • Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update. 2008;14:543–552.
  • Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat. 2009;117:561–567.
  • Gerber B, von Minckwitz G, Stehle H, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study. J Clin Oncol. 2011;29:2334–2341.